These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Hypochondriasis and its relationship to obsessive-compulsive disorder. Fallon BA; Qureshi AI; Laje G; Klein B Psychiatr Clin North Am; 2000 Sep; 23(3):605-16. PubMed ID: 10986730 [TBL] [Abstract][Full Text] [Related]
9. Clinical predictors of drug nonresponse in obsessive-compulsive disorder. Shetti CN; Reddy YC; Kandavel T; Kashyap K; Singisetti S; Hiremath AS; Siddequehusen MU; Raghunandanan S J Clin Psychiatry; 2005 Dec; 66(12):1517-23. PubMed ID: 16401151 [TBL] [Abstract][Full Text] [Related]
10. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder. Mataix-Cols D; Rauch SL; Manzo PA; Jenike MA; Baer L Am J Psychiatry; 1999 Sep; 156(9):1409-16. PubMed ID: 10484953 [TBL] [Abstract][Full Text] [Related]
11. Combination treatment with clomipramine and selective serotonin reuptake inhibitors for obsessive-compulsive disorder in children and adolescents. Figueroa Y; Rosenberg DR; Birmaher B; Keshavan MS J Child Adolesc Psychopharmacol; 1998; 8(1):61-7. PubMed ID: 9639080 [TBL] [Abstract][Full Text] [Related]
12. [Obsessive-compulsive disorder in childhood and adolescence]. Hoshino Y Ryoikibetsu Shokogun Shirizu; 2003; (40):106-10. PubMed ID: 14626078 [No Abstract] [Full Text] [Related]
13. Pharmacological treatment strategies in obsessive compulsive disorder: A cross-sectional view in nine international OCD centers. Van Ameringen M; Simpson W; Patterson B; Dell'Osso B; Fineberg N; Hollander E; Hranov L; Hranov G; Lochner C; Karamustafalioglu O; Marazziti D; Menchon JM; Nicolini H; Pallanti S; Stein DJ; Zohar J J Psychopharmacol; 2014 Jun; 28(6):596-602. PubMed ID: 24429223 [TBL] [Abstract][Full Text] [Related]
14. Postpartum onset obsessive-compulsive disorder: diagnosis and management. Brandes M; Soares CN; Cohen LS Arch Womens Ment Health; 2004 Apr; 7(2):99-110. PubMed ID: 15083345 [TBL] [Abstract][Full Text] [Related]
15. [Obsessive-compulsive disorders in general practice. How the obsessive-compulsive neurotic is revealed by skin and hair]. Kordon A; Broocks A; Hohagen F MMW Fortschr Med; 2003 May; 145 Suppl 2():4-7. PubMed ID: 14579475 [TBL] [Abstract][Full Text] [Related]
16. Chronic medication does not affect hyperactive error responses in obsessive-compulsive disorder. Stern ER; Liu Y; Gehring WJ; Lister JJ; Yin G; Zhang J; Fitzgerald KD; Himle JA; Abelson JL; Taylor SF Psychophysiology; 2010 Sep; 47(5):913-20. PubMed ID: 20230510 [TBL] [Abstract][Full Text] [Related]
17. Agomelatine augmentation in obsessive compulsive disorder: a preliminary report. Tzavellas E; Karaiskos D; Ilias I; Liappas I; Paparrigopoulos T Psychiatriki; 2014; 25(3):179-84. PubMed ID: 25367661 [TBL] [Abstract][Full Text] [Related]
18. Citalopram intravenous infusion in resistant obsessive-compulsive disorder: an open trial. Pallanti S; Quercioli L; Koran LM J Clin Psychiatry; 2002 Sep; 63(9):796-801. PubMed ID: 12363120 [TBL] [Abstract][Full Text] [Related]
19. Adults with early-onset obsessive-compulsive disorder. Rosario-Campos MC; Leckman JF; Mercadante MT; Shavitt RG; Prado HS; Sada P; Zamignani D; Miguel EC Am J Psychiatry; 2001 Nov; 158(11):1899-903. PubMed ID: 11691698 [TBL] [Abstract][Full Text] [Related]
20. [Evidence-based pharmacotherapy and other somatic treatment approaches for obsessive-compulsive disorder: state of the art]. Kordon A; Zurowski B; Wahl K; Hohagen F Nervenarzt; 2011 Mar; 82(3):319-20, 322-4. PubMed ID: 21340636 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]